GGrantIndex
← Leaderboards

Jin Mo Park

Massachusetts General Hospital

$8,956,617
Attributed
$8,956,617
Total exposure
6
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $778.4K · FY200825
$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$8,956,617 · 6

By mechanism

R01$8,501,071 · 5
R21$455,546 · 1

Top collaborators

No co-investigators on record.

Most similar at Massachusetts General Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Cells

Research focus

CellsSignal TransductionLinkMediatingGene ExpressionEventInflammationImmune SystemTissuesPreventResponseReceptorEpithelial CellsKeratinocytePlayExhibitsBaseGenesSkinImmuneIn VivoKnockout MiceMouse ModelInflammatory Response

Grant awards (23)

Staphylococcal protease-mediated epithelial barrier perturbation and allergen sensitization$635,901
R01 · FY2025 · AI · contact PI
Staphylococcal protease-mediated epithelial barrier perturbation and allergen sensitization$654,834
R01 · FY2024 · AI · contact PI
MMP13 expression and function in allergic inflammation$407,286
R01 · FY2021 · AI · contact PI
Immune responses to commensal bacterial spores in the intestinal mucosa$206,773
R21 · FY2021 · AI · contact PI
MMP13 expression and function in allergic inflammation$407,286
R01 · FY2020 · AI · contact PI
Immune responses to commensal bacterial spores in the intestinal mucosa$248,773
R21 · FY2020 · AI · contact PI
MMP13 expression and function in allergic inflammation$407,286
R01 · FY2019 · AI · contact PI
MMP13 expression and function in allergic inflammation$407,286
R01 · FY2018 · AI · contact PI
Erythropoietin receptor-driven tumor initiation and progression$346,478
R01 · FY2018 · CA · contact PI
MMP13 expression and function in allergic inflammation$407,286
R01 · FY2017 · AI · contact PI
Erythropoietin receptor-driven tumor initiation and progression$346,478
R01 · FY2017 · CA · contact PI
Erythropoietin receptor-driven tumor initiation and progression$346,478
R01 · FY2016 · CA · contact PI
Erythropoietin receptor-driven tumor initiation and progression$346,478
R01 · FY2015 · CA · contact PI
Erythropoietin receptor-driven tumor initiation and progression$346,478
R01 · FY2014 · CA · contact PI
Regulatory targets of p38 MAP kinase in inflammation$357,584
R01 · FY2013 · AI · contact PI
Regulatory targets of p38 MAP kinase in inflammation$380,409
R01 · FY2012 · AI · contact PI
Regulatory targets and pathogenic mechanisms of anthrax edema factor$383,714
R01 · FY2011 · AI · contact PI
Regulatory targets of p38 MAP kinase in inflammation$380,409
R01 · FY2011 · AI · contact PI
Regulatory targets and pathogenic mechanisms of anthrax edema factor$387,590
R01 · FY2010 · AI · contact PI
Regulatory targets of p38 MAP kinase in inflammation$384,251
R01 · FY2010 · AI · contact PI
Regulatory targets and pathogenic mechanisms of anthrax edema factor$391,324
R01 · FY2009 · AI · contact PI
Regulatory targets of p38 MAP kinase in inflammation$387,073
R01 · FY2009 · AI · contact PI
Regulatory targets and pathogenic mechanisms of anthrax edema factor$389,162
R01 · FY2008 · AI · contact PI